To further test the effects of the mutSF30A allele on MMR, we fused mutL to gfp to determine if the MutSF30A, which forms foci independent of mismatch binding, could elicit the downstream step of MutL-GFP focus formation. When native mutS is upstream of mutL-gfp, we found that ~16% of cells form MutL-GFP foci untreated (Fig S2) . Challenge of MutL-GFP cells with 2-AP or placement into a genetic background containing a proofreading deficient polC exo-allele, we found an increase in the percent of cells with foci to ~36% and ~33% of cells respectively (Fig S2) . This result shows that mismatches stimulate MutL to form foci in vivo. In contrast, a strain with a clean deletion of the mutS coding region showed a striking reduction in the percent of cells with MutL-GFP foci (<3% of cells) and in the absence of mutS, MutL-GFP foci were not stimulated by treatment with 2-AP ( Fig S2) . We asked if mismatch binding by MutS was required to elicit MutL-GFP foci. We show when mutSF30A replaces mutS, MutL-GFP foci formed in ~11% of cells. These foci were qualitatively dim relative to MutL-GFP foci that form in a mutS + strain.
MutL-GFP colocalizes with the replication apparatus. We also characterized the ability of MutL-mCherry to colocalize with the replisome. We constructed a strain with both dnaX-gfp and mutL-mCherry alleles, where both were integrated at their native locus and expressed from their native promoters. In exponentially growing cells, MutL-mCherry colocalized with the replisome at levels comparable to MutS (~59%, n=130) (Fig 3D) . This result is different from results obtained in S. cerevisiae, where the Mlh1-PMS1 foci are not coincident with replication centers (Hombauer et al., 2011) . It should be noted however, that MutL foci in both organisms are dependent on MutS. When challenged with 2-AP, MutL-mCherry was reduced for colocalized with the replisome to ~49% (p=0.0568). Because MutL-GFP foci behave similarly to MutS-GFP foci when treated with 2-AP, we speculate that MutL may be poised with MutS at the replisome waiting for mismatch identification by MutS. We further speculate that upon the initiation of repair, MutL associates with the repair complex and moves away from the replisome in a complex that can be observed by fluorescence microscopy.
Experimental Procedures MutS and MutSF30A protein purification
MutS and MutSF30A were overexpressed from pET11t-mutS and -mutSF30A respectively in E. coli BL21 DE3 using standard procedures . Cell pellets were resuspended in resuspension buffer (20 mM Tris HCl (pH 7.6), 500 mM NaCl, 4 mM DTT, 20 mM spermidine trihydrochloride, and 0.5 mM EDTA) and lysed by passage through a French pressure cell (3 passes at a setting of 15,000 PSI). Cells debris was pelleted at 15,000 rpm for 30 min at 4˚C. All subsequent protein purification steps were performed on ice or at 4˚C. Solid ammonium sulfate was added in order to achieve 30% saturation of the supernatant. Precipitated protein was removed by centrifugation at 15,000 rpm for 30 minutes. The supernatant was collected and ammonium sulfate was added to 40% saturation, which preferentially precipitated MutS and MutSF30A. Precipitated protein was removed via centrifugation at 15,000 rpm for 30 min and flash frozen in liquid N 2 and stored at -80˚C.
The pellet was thawed on ice and then resuspended in buffer QA (20 mM Tris HCl (pH 7.6), 100 mM NaCl, 1 mM DTT, 0.5 mM EDTA, and 10% glycerol). Once the pellet was resuspended, the sample was desalted using HiPrep 26/10 desalting column (GE Healthcare, Uppsala, Sweden) pre-equilibrated in buffer QA. This material was further purified with a HiTrap Q HP column (GE Healthcare, Uppsala, Sweden) pre-equilibrated in Buffer QA. MutS and MutSF30A were eluted with a 20 column volume gradient (from 100 mM NaCl to 600 mM NaCl). MutS and MutSF30A containing fractions were pooled and once again desalted with a HiPrep 26/10 desalting column pre-equilibrated in Buffer HA1 (5 mM potassium phosphate (pH 7.4), 30 mM NaCl, 1 mM DTT, and 10% glycerol). The desalted sample was purified with a hydroxyapatite Bio-Scale Mini CHT Type 1 column (Bio-Rad) and eluted with a phosphate gradient (5 mM-400 mM) over 20 column volumes. Protein samples were concentrated with a Vivaspin 20 concentrator (GE Healthcare-28-9323-62) with a 50 kDa molecular weight cutoff and then desalted with a HiPrep 26/10 column using the following storage buffer (20 mM Tris HCl (pH 7.6), 200 mM NaCl, 4 mM DTT, and 10% glycerol). Samples were again concentrated with a Vivaspin 20 concentrator and aliquoted into small usable samples and flash frozen in liquid N 2.
MutS and MutSF30A behaved identically throughout the purification process, indicating similar biochemical characteristics. Absorbance spectra were obtained using a 50-Bio UV Spectrophotometer (Varian, Palo Alto, CA) in both the natured state (storage buffer) and denatured state (storage buffer with 6M Guanidine HCl). No light scattering was observed from 300-600 nm in the native conditions, indicating the protein did not aggregate. In addition, significant absorbance was not detected at 250 nm indicating nucleotides were not present. All protein concentrations were determined using extinction coefficients derived at ExPASy Proteomics Server (http://expasy.org/). DnaN was purified as described previously (Klocko et al., 2011) .
Construction of an unmarked-in frame mutSF30A mutant allele
In order to introduce the mutSF30A allele into the B. subtilis chromosome, we used the pMiniMAD2 vector as described (Patrick & Kearns, 2008) . The pMiniMAD2 vector contains an erythromycin cassette, as well as a temperature sensitive origin of replication. Plasmid pJSL44 was introduced into PY79 via Campbell-type integration at the restrictive temperature (37˚C) for replication, selecting for integration of the plasmid into the chromosome by mls selection. After the initial Campbell type integration, pJSL44 was evicted as described (Patrick & Kearns, 2008) .
To rid the strain of the integrated plasmid, transformed colonies were grown in 3 ml of LB broth at a permissive temperature for plasmid replication (22°C) for 14 hr, diluted 30-fold in fresh LB broth and incubated at 22°C for another 8 hr. This process was continued over three successive days, and then serial dilutions were plated on LB agar at 37°C. Colonies were then colony purified on LB at the restrictive temperature and tested for mls resistance. Strains that were sensitive to mls selection were screened for increased spontaneous mutagenesis, consistent with a mismatch repair defect. The mutS gene was sequenced from clonal isolates showing a high increase in mutagenesis to verify the presence of the F30A change and to confirm that no other base changes were present.
Construction of an unmarked-in frame ΔmutS mutant allele
The ΔmutS allele was built in a similar way to the unmarked-in frame mutSF30A mutant allele.
Differences are that a 500 bp region upstream of mutS was amplified with primers JSL 156/157 (insert A) and a 500 bp region downstream of mutS was amplified with pJSL 158/159 (insert B).
Furthermore, we amplified the pMiniMAD2 vector (previously cut with KpnI in order to linearize the plasmid) with pJS282/283 to obtain a ~6.3 kB linear PCR product. These DNA fragments all maintained 20-25 bp of sequence homology between adjacently targeted segments.
The two inserts, along with the prepared pMiniMAD2 vector were fused using sequence and ligation-independent cloning (SLIC) (Li & Elledge, 2007) . The ΔmutS was integrated into the chromosome as described above for the mutSF30A mutant allele. The final strain was ΔmutS, as Thymidine incorporation to monitor DNA synthesis B. subtilis cells were grown in S7 50 minimal media supplemented with 2% glucose at 37˚ C from an initial starting inoculum of 0.050. When the cells reached mid-exponential phase, 1.8 mL of culture was pulse labeled with 45 µL of 3 H-thymidine (50 Ci/mmol; 1 mCi/mL) and incubated at 37˚ C. At the appropriate time points (30, 120, 300 and 600s), 0.4 mL of culture were removed and mixed into 3 mL of ice cold 10% TCA and incubated on ice for ≥30 min. Samples were filtered on glass microfibre filters (GF/C, Whatman) by vacuum. Each filter was washed three times with 5 mL ice-cold 10% TCA, followed by three additional washes with 5 mL of -20˚C 70% ethanol. Filters were dried, and incorporated 3 H-thymidine into acid insoluble material during replication was was quantified using scintillation spectroscopy.
Plasmid construction
pJSL30 was constructed in order to place mutS-gfp expression under the control of the P spac promoter at the ectopic amyE locus. The mutS gene was amplified from B. subtilis (PY79) chromosomal DNA using the primers oJSL81 and oJSL82. The insert was gel purified, digested with Sal I and Xho I, PCR purified, and ligated into pBS226 with the original mutL insert removed.
pJSL35 was constructed to knock out the mismatch detection capability of pJSL30 by introducing mutSF30A. To do so, pJSL30 was subject to site-directed mutagenesis using standard protocol (Zheng et al., 2004) to produce the F30A mutation using the primers oJSL125 and oJSL126.
pJSL36 was constructed to generate the mutSF30A mutant allele at the native locus by allelic replacement (Patrick & Kearns, 2008) . The sequence spanning from 457 bases upstream of the mutS +1 base to 570 bases downstream was PCR amplified from the B. subtilis PY79 chromosomal DNA using the primers oJSL123 and oJSL124. The fragment was gel extracted, digested with Bam HI and Kpn I, and ligated into pMiniMAD2. pMiniMAD2 contains an erythromycin cassette, as well as a temperature sensitive origin of replication (37˚).
pJSL40 was constructed to place codon optimized (C.o.) and monomeric CFP downstream of dnaX for native locus integration. C.o. cfp was amplified from pDR200 (Doan et al., 2005) with primers oJSL127 and oJSL128. The fragment was gel purified, cut with restriction enzymes Sph I and Xho I, and ligated into pKL147 with the gfp insert removed.
pJSL44 was constructed to knock out the mismatch detection capability of MutS at its native locus. pJSL44 is pJSL36 with the F30A mutation introduced by site-directed mutagenesis (Zheng et al., 2004) . The primers used for site-directed mutagenesis reaction oJSL125 and oJSL126.
pJSL45 was constructed to overexpress wild type recombinant MutSF30A. The F30A was introduced into pET11t-mutS using primers oJSL125 and oJSL126.
pJSL57 (See supplemental methods)
pJSL58 was constructed to place mutS800 under the control of a P spac promoter at the amyE ectopic locus. The mutS800 allele was PCR amplified from the B. subtilis chromosome using primers oJSL178 and oJSL179. We gel purified and digested the PCR fragment with SphI and NheI, followed by a PCR clean-up step (Qiagen). Finally, the digested fragment was ligated into pDR110 following digestion with the same restriction enzymes.
pJSL63 was constructed to place mutS800-gfp under the control of the P spac promoter at the amyE ectopic locus. The mutS800 allele was PCR amplified from the B. subtilis chromosome using primers oJSL81 and oJSL133. The PCR product was digested with Xho I and Sal I followed by gel purification. This digested fragment was ligated into opened pBS226.
pJSL64 was constructed to place mutSF30A800-gfp under the control of the P spac promoter at the amyE ectopic locus. This construct is derived from pJSL63, where the F30A was introduced by site-directed mutagenesis (Zheng et al., 2004) into the plasmid using primers oJSL125 and pJSL126.
pJSL67 was constructed for localizing DnaX within the cell using the mCherry fluorophore. The dnaX-mCherry was PCR amplified from pJSL52 (pKL147-dnaX-mCherry) using primers oJSL170 and 171. Using SLIC (see methods), the insert was ligated into pBGSC6 that was amplified using primers JSL168 and oJSL169.
All constructs were sequenced prior to use (University of Michigan core sequencing facility). Figure S1 . Response of MutS-GFP to the intrinsic error rate in vivo. Shown is a bar graph of the percent of cells with foci for MutSF30A-GFP with (+) and without (-) 2-AP compared to cells with MutS-GFP foci in the absence of 2-AP challenge. The p-values indicate the difference between the percent of cells with foci between each group shown. MutSF30A-GFP and MutS-GFP untreated are statistically significant. The data presented here is the same as in Figure 2C . This construct (JSL281) represents a deletion of mutS that maintains mutL under the control of its native promoter. The start codon of mutS (ATG) replaces the start codon of mutL (GTG) in order to ensure mutL expression. Steady state levels of MutL in this background were ~2-3 fold higher than that observed when mutS + is upstream (Fig 1D) . 
Figure S7. Quantifying ectopic expression of MutS800
Relative protein levels of MutS800 were determined by performing immunoblot analysis followed by quantification using Image J software (http://rsb.info.nih.gov/ij/). Total band intensities were determined by subtracting the background signal from the ΔmutSL lane followed by normalization to the total protein load determined from analysis of the DnaN band intensity. The relative enrichment was determined from 3 independent samples with the standard deviation shown. 
